Skip to main content
NIH funding notice RFA-HD-14-034

Male Contraceptive Development Program (U01)

Closed on August 11, 2014.

Posted
June 10, 2014
Close date
August 11, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $517,423 in first-year total cost, median $258,712.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-L (50)]2

Most frequent institutions

  1. LURIE CHILDREN'S HOSPITAL OF CHICAGO1
  2. UNIVERSITY OF PENNSYLVANIA1
Competing awards under RFA-HD-14-034 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Targeting the piRNA pathway and meiotic recombination for male contraception1U01HD084007-01WANG, PEIJING JEREMYUNIVERSITY OF PENNSYLVANIA, PA$280,000ZHD1
2015Deubiquitinating Enzymes as Targets for Male Contraception1U01HD084046-01PAYNE, CHRISTOPHER JESSLURIE CHILDREN'S HOSPITAL OF CHICAGO, IL$237,423ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HD-14-034: Male Contraceptive Development Program (U01) | ScienceDex | ConductScience